<DOC>
	<DOCNO>NCT00795509</DOCNO>
	<brief_summary>The objective surveillance collect information 1 ) adverse drug reaction expect LPD ( unknown adverse drug reaction ) , 2 ) incidence adverse drug reaction surveillance , 3 ) factor consider affect safety and/or efficacy drug .</brief_summary>
	<brief_title>Special Investigation For Long Term Use Of Tolterodine ( Regulatory Post Marketing Commitment Plan ) .</brief_title>
	<detailed_description>All patient investigator prescribes first Detrusitol® Capsule register consecutively number subject reach target number order extract patient enrol investigation random .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Patients need administer Detrusitol® Capsule order enrol surveillance . Patients administer Detrusitol® Capsule .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>